New insights into pain relief drugs

July 4, 2014
Photo by Jonathan Lindberg for Coast Guard

(Medical Xpress)—Scientists from the Research School of Biology have opened the door to a new world of pain treatments with their discovery of the exact way that pain relief drugs, such as anaesthetics, work on the body.

Dr Ben Corry and Lewis Martin developed a detailed computer model that revealed for the first time how benzocaine, a local anaesthetic, and phenytoin, an anti-epilepsy , enter into and prevent the signals being transmitted to the brain.

"By understanding how the current range of drugs work we can best design the next generation, to better treat conditions such as , epilepsy and cardiac arrhythmia," said Dr Corry.

The precise knowledge of how the drug molecules attach to proteins in the nerve cell give a springboard for redesigning drugs without the side-effects that current drugs bring with them.

Their work, from the Research School of Biology at ANU is published in the latest edition of PLOS Computational Biology.

Local anaesthetics were first inspired by cocaine and have been in use for more than 100 years, but the exact mechanism has not been understood until now.

The pair used more than three million CPU hours on the National Computational Infrastructure's supercomputer to simulate the drug's route into the nerve cell.

The video will load shortly

Pain signals are transmitted to the brain when proteins that act as tiny gateways in nerve cell walls open, allowing sodium and potassium ions to pass through. The simulation shows that the drug's final binding site is inside the sodium gateway protein, which blocks it and prevents the signal from being transmitted.

Drugs that block sodium channels are also used to treat nerve-signal disorders such as epilepsy or heart arrhythmia. However, the current drugs target sodium channels indiscriminately throughout the body, which can lead to side effects.

Dr Corry says pharmaceutical companies are especially interested developing new drugs designed to selectively target the subtly-differing proteins in specific locations of the body, such as the heart or brain.

"Knowledge of the fine molecular detail of the drug opens up possibilities to conceive ," says Dr Corry. "Chronic pain is a big market, and an avenue I'd also like to pursue is developing antibiotics based on this approach."

Explore further: New pain relief targets discovered

Related Stories

New pain relief targets discovered

April 17, 2014
Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. BBSRC-funded researchers at King's College London made the discovery when researching how pain occurs ...

Researcher develops model to foster new drug development to treat pain and epilepsy

December 12, 2011
Drawing on X-ray crystallography and experimental data, as well as a software suite for predicting and designing protein structures, a UC Davis School of Medicine researcher has developed an algorithm that predicts what has ...

Can injuries to the skin be painless?

June 19, 2014
When the body receives an injury to the skin, a signal is sent to the brain, which generates a sensation of pain. Teams led by Priscille Brodin in Lille and Laurent Marsollier in Angers have studied lesions in patients with ...

Study identifies new drug target for chronic, touch-evoked pain

March 10, 2014
(Medical Xpress)—Researchers at the School of Medicine have identified a subset of nerve cells that mediates a form of chronic, touch-evoked pain called tactile allodynia, a condition that is resistant to conventional pain ...

Recommended for you

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

Omega-3 fatty acids fight inflammation via cannabinoids

July 18, 2017
Chemical compounds called cannabinoids are found in marijuana and also are produced naturally in the body from omega-3 fatty acids. A well-known cannabinoid in marijuana, tetrahydrocannabinol, is responsible for some of its ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.